Nkure Therapeutics-preview

Nkure

Nkure Therapeutics

Private

Bangalore UrbanHealthcare & Life Scienceshttps://www.nkure.com/

Last Round

Seed

Apr 26, 2023

Company Overview

Nkure Therapeutics is a biotechnology company developing affordable natural killer (NK) cell-based immunotherapies for cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

NK cell therapyallogeneic cell therapyoff-the-shelf cell therapycell therapygene therapycancer immunotherapyclinical-stage biotechaffordable cancer treatmentCAR T therapyallogeneic CAR Tbiopharmaceutical developmentsolid tumor treatmentCDMOcontract development and manufacturing organizationB-cell malignancies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nkure Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nkure Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 26, 2023

View all Funding Rounds

Nkure Therapeutics Investors

Notable investors and investment history

Investor	Rounds
Endiya Partners	Seed
Innovative Quest Private Limited	Seed
Kotak Alternate Asset Managers	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 7, 2025
Partnering with CRISPR Therapeutics to co-develop CAR T therapy CTX112(TM).
May 7, 2025
Partnering with CRISPR Therapeutics to co-develop CAR T therapy for oncology.

View all signals

Nkure Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nkure Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nkure Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore Urban

Employee Range13

Year Founded2022

Last FundingApr 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.